REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Bristol-Myers Squibb Co. (NY: BMY)
46.44 USD  -0.36 (-0.77%)
Official Closing Price  /  Updated: 6:40 PM EDT, Jun 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Bristol-Myers Squibb Co.
 
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Supreme Court Ruling Creates Uncertainly for Drug Makers (ACT) (MYL) (MRK)
June 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8422776 for the full story. Read More
from StreetInsider.com News Articles
USMV, BMY, PEP, CB: ETF Outflow Alert
June 17, 2013
Symbols mentioned in this story: USMV, BMY, PEP, CB Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Cramer: A 'Nightmare Scenario' for Bulls and Bears
June 17, 2013
Jim Cramer has become more cautious on the market right now and conditions are creating a "nightmare scenario" for just about everyone involved, he said on CNBC. Read More
category General Mills Inc , Squawk on the Street , tv6in60 , and 2 more.
from CNBC.com News
BCG Weighs In On First-In-Class Vs. Best-In-Class Drugs -- How Valuable Is Their Advice?
June 17, 2013
The hardest decisions facing a head of a pharmaceutical R&D organization involve determining which great ideas to fund. One might think this is a simple process, that any idea which can lead to a new... Read More
category NYSE:PFE , NYSE:BMY
from Forbes Real Time
UK scientists win funding for new kind of anticoagulant drug
June 16, 2013
LONDON, June 17 (Reuters) - British scientists have won early financial backing for a new kind of anticoagulant drug they believe may prevent dangerous blood clots without causing bleeding - a... Read More
category companyNews
from Reuters: Company News
Bristol-Myers Squibb, AbbVie Announce Progression-Free Survival Data from Phase 2 Multiple Myeloma Study
June 15, 2013
Bristol-Myers Squibb Company (NYSE: BMY ) and AbbVie (NYSE: ABBV ) today announced updated efficacy and safety data from a small, randomized Phase 2, open-label study in patients with... Read More
category Contracts , ABBV , Management , and 5 more.
from Latest Articles from Benzinga.com
Week in Review: Mindray Medical Buys US Ultrasound Company for $105 Million
June 15, 2013
Mindray Medical will pay $105 million to acquire Zonare Medical Systems, a California high-end ultrasound device maker; Simcere Pharma announced a third drug development collaboration with... Read More
from ChinaBio® Today
4 Pharmaceutical Stocks to Buy Now
June 14, 2013
 Read More
category NYSE:JNJ , NYSE:WPI , Stocks to Buy , and 2 more.
from InvestorPlace - Latest Headlines
Simcere Announces Third Drug Development Partnership with BMS
June 14, 2013
Simcere Pharma has formed a third drug development collaboration with Bristol-Myers Squibb. For the first time, the project involves a biologic molecule: a subcutaneous formulation of Orencia®, a... Read More
from ChinaBio® Today
It’s Time to ‘Put’ Your Big Winners in Protection Mode
June 14, 2013
 Read More
category NASDAQ:MU , NASDAQ:APOL , NASDAQ:MNST , and 3 more.
from InvestorPlace - Latest Headlines
Cramer: How to Ride Out the Weakness
June 12, 2013
"I'm not crazy about the market," Cramer said. "We have taken my charitable trust's cash position to a much higher level than usual," revealed the Mad Money host on Wednesday's broadcast. Read More
category Investing , Investing/Market Outlook , General Mills Inc , and 11 more.
from CNBC.com News
Drugmakers to cooperate in safety review of diabetes drugs
June 12, 2013
NEW YORK, June 12 (Reuters) - Global drugmakers said on Wednesday they would cooperate with an independent review to address concerns of a potential link between widely used diabetes medicines and... Read More
category companyNews
from Reuters: Company News
Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB)
June 12, 2013
Among biotech and emerging pharmaceutical companies, Biogen Idec (NASDAQ: BIIB ), saw the most significant rise in short interest between the May 15 and May 31 settlement dates. The number of shares... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Astrazeneca, Bristol-Myers Squibb Release Statement to American Diabetes Association
June 12, 2013
Earlier this week, the American Diabetes Association called for manufacturers of incretin-based therapies to make patient-level data available from clinical trials for an independent analysis of... Read More
category AZN , Benzinga , News , and 1 more.
from Latest Articles from Benzinga.com
Bristol-Myers Squibb Shares Up 13.7% Since SmarTrend's Buy Recommendation (BMY)
June 12, 2013
from Comtex SmarTrend® News Briefs
UPDATE 1-Former Bristol-Myers executive admits to insider trading
June 10, 2013
* Defendant accused of buying options in takeover targets Read More
category companyNews
from Reuters: Company News
Former Bristol-Myers executive admits to insider trading
June 10, 2013
A former Bristol-Myers Squibb Co finance executive on Monday pleaded guilty to an insider trading charge, admitting to buying stock options in a biotechnology company that the drugmaker was preparing... Read More
from FOX News
Former Bristol-Myers executive admits to insider trading
June 10, 2013
* Defendant accused of buying options in takeover targets Read More
category companyNews
from Reuters: Company News
Ex-Bristol-Myers executive admits to insider trade
June 10, 2013
Robert Ramnarine, who was involved with evaluating potential acquisition targets for Bristol-Myers Squibb, admitted to illicit gains from trading in stock options of several of the pharmaceutical... Read More
category Market News , Biotechnology , General , and 7 more.
from MarketWatch
4 High-Fliers That Could Crash-Land Soon
June 10, 2013
 Read More
category NYSE:JNJ , Stocks to Sell , NYSE:BMY , and 3 more.
from InvestorPlace - Latest Headlines
Jefferies Lowers Price Target on Bristol Myers Squibb; Maintains “Buy” Rating (BMY)
June 10, 2013
Following a review of global pharmaceutical stocks, analysts at Jefferies lowered the price target on Bristol Myers Squibb Co. (BMY) on Friday, but maintained a bullish rating on the New York-based... Read More
category bmy , Bristol Myers Squibb Co/ , Dividend Stocks
from Dividend Daily
Top-Performing Dividend Payers in Health Care with the Most Upside Potential (AET, ENSG, QCOR)
June 08, 2013
It is not unusual for stocks on a tear to overrun their mean price targets, which is a signal of how far analysts on average expect the share price to climb. Some of the top-performing health care... Read More
category skilled healthcare group , Benzinga , Trading Ideas , and 25 more.
from Latest Articles from Benzinga.com
FDA grants priority review status to Gilead's hepatitis C drug
June 07, 2013
June 7 (Reuters) - Biotechnology company Gilead Sciences Inc said the U.S. Food and Drug Administration (FDA) granted priority review to its experimental hepatitis C drug sofosbuvir. Read More
category companyNews
from Reuters: Company News
4 Call Contenders: Pharmaceuticals
June 07, 2013
 Read More
category NASDAQ:IMMU , NYSE:MRK , NYSE:ELN , and 1 more.
from InvestorPlace - Latest Headlines
UPDATE: Jefferies Lowers PT on Bristol-Myers Squibb Following Global Pharma Review
June 07, 2013
In a report published Friday, Jefferies analyst Jeffrey Holford reiterated a Buy rating on Bristol-Myers Squibb Co. (NYSE: BMY ), but lowered the price target from $53.50 to $53.00. In the report,... Read More
category Benzinga , Jeffrey Holford , Price Target , and 4 more.
from Latest Articles from Benzinga.com
Sanofi steps up diabetes drive as rivals raise the stakes
June 07, 2013
* Investing in smart technology to bolster diabetes business Read More
category companyNews
from Reuters: Company News
4 Pharmaceutical Stocks to Buy Now
June 07, 2013
 Read More
category NYSE:JNJ , NYSE:WPI , Stocks to Buy , and 2 more.
from InvestorPlace - Latest Headlines
XLF, PTH: Big ETF Inflows
June 05, 2013
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, the largest inflow was seen in the Financial Select Sector SPDR Fund (XLF), which added... Read More
category ETFs
from ETF Channel
StockCall Pre-Market Review on BMY, LLY, ENDP, and AGN
June 05, 2013
from ACCESSWIRE
Merck’s Shares Jump On New Clinical Trial Data
June 04, 2013
category Pharmaceuticals
from Trefis
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here